Federal Register #FDA-2026-N-1536

FDA Issues Permanent Debarment Order Against Individual for Felony Related to Drug Development

This notice announces a final debarment order issued by the Food and Drug Administration (FDA) against Angela Anatilde Baquero. - Government Buyer: - Department of Health and Human Services (HHS) - Food and Drug Administration (FDA) - Action: Permanent debarment of Angela Anatilde Baquero from providing services in any capacity to any person with an approved or pending drug product application - Reason: Felony conviction under Federal law related to the development or approval of drug products - Scope: - Prohibits involvement in any drug product applications regulated by the FDA - Applies to all drug product applications under the Federal Food, Drug, and Cosmetic Act - No OEMs, vendors, products, or purchase quantities are involved, as this is an enforcement action, not a procurement or award - The debarment is effective immediately and is permanent

Description

The Food and Drug Administration (FDA) is issuing a final order permanently debarring Angela Anatilde Baquero from providing services in any capacity to a person with an approved or pending drug product application. This action follows her conviction of a felony related to the development or approval of drug products. Ms. Baquero was notified of the proposed debarment and given an opportunity to request a hearing but did not respond, waiving her right to a hearing. The debarment is effective August 3, 2026, and prohibits her from involvement in drug product applications.

View original listing